Kentucky HB 346: AN ACT relating to biosimilar medicines.

Status: to Committee on Committees (H) (as of 2023-02-16)

State: Kentucky · Session: 2023RS · Bill: HB 346

Subjects: Drugs and Medicines, Health and Medical Services, Insurance, Health, Pharmacists

View Kentucky HB 346 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.